Form 4 for NBIX NEUROCRINE BIOSCIENCES INC
Accepted 2024-08-16 00:00:00 ET · period of report 2024-08-15 · accession 0000914475-24-000197 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-08-16 | 2024-08-15 | NBIX | RASTETTER WILLIAM H | Dir | S - Sale | $146.69 | -14.2K | 37.5K | -28% | -$2.09M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-08-15 | S | D | 14,250 | $146.69 | 37,491 | D | — | — | (F1) The Reporting Person contributed Issuer common stock to an exchange fund for shares of the exchange fund. The Issuer common stock was valued at $146.69 per share for the purpose of determining the number of shares of the exchange fund issuable to the Reporting Person. (F2) All of the reported shares are held by the Rastetter Family Trust established September 2, 2010, of which the Reporting Person has voting and investment power. |